Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Novartis AG entered a landmark collaboration with Cleara Biotech worth up to EUR 280 million in November 2025
This apparent paradox can be reconciled by conceptualizing ACSL4 as a context-dependent metabolic switch
1-2 months on, 1-2 months off for ongoing protocols Research status: The bulk of the evidence base comes from in vitro studies and animal models, with a small number of human cosmetic trials (8-12 week topical application) confirming effects on skin density, wrinkle volume, and collagen production
OConnor C, White KL, Doncescu N et al (2015) NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor
Seyed Khoei N, Jenab M, Murphy N, Banbury BL, Carreras-Torres R, Viallon V, et al
US$ 22.77
US$ 26.16
US$ 26.15
US$ 21.04
US$ 24.28
US$ 22.33
